ABSTRACT
Antiphospholipid syndrome (APS) can occur in children, like adults, with the same diverse spectrum of thrombotic sites but predominately with deep vein thrombosis and stroke. In contrast with adults, however, transient nonthrombogenic antiphospholipid (aPL) antibodies are seen more commonly, usually after childhood infections. In those with “true” aPL antibodies, recurrent thrombotic events seem less frequent than in adults, perhaps reflecting the less prothrombotic hemostatic state of childhood.
Children with thrombotic events in APS present difficult management problems, as there is little evidence-based medicine. The duration and intensity of anticoagulation are unresolved management issues, but a target international normalized ratio of 2 to 3 is used by most. Multicenter randomized controlled trials would provide answers to some of these issues but are difficult to organize due to ethical issues and the rarity of the condition. A pediatric APS registry such as the Ped-APS Register is more easy to organize and can yield informative data.
KEYWORDS
Antiphospholipid antibodies - antiphospholipid syndrome - children
REFERENCES
-
1
Harris E N, Gharavi A E, Boey M L et al..
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.
Lancet.
1983;
2
1211-1214
-
2
Hughes G RV, Harris A E, Gharavi A E.
The anticardiolipin syndrome.
J Rheumatol.
1986;
13
486-489
-
3
Miyakis S, Lockshin M D, Atsumi T et al..
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
J Thromb Haemost.
2006;
4
295-300
-
4
Wise R C, Todd J K.
Spontaneous lower extremity venous thrombosis in children.
Am J Dis Child.
1973;
126
766-769
-
5
Andrew M, David M, Adams M et al..
Venous thromboembolic complications (VTE) in children: first analysis of the Canadian Registry of VTE.
Blood.
1994;
83
1251-1257
-
6
Nowak-Gottl U, Koch H G, Aschka I et al..
Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism.
Br J Haematol.
1996;
92
992-998
-
7
Broderick J, Talbot G T, Prenger E.
Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage.
J Child Neurol.
1993;
8
250-255
-
8
Williams L S, Garg B P, Cohen M et al..
Subtypes of ischemic stroke in children and young adults.
Neurology.
1997;
49
1541-1545
-
9
Avcin T, Silverman E D.
Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.
Lupus.
2007;
16
627-633
-
10
Galli M, Comfurius P, Maassen C et al..
Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor.
Lancet.
1990;
335
1544-1547
-
11
Miyakis S, Lockshin M D, Atsumi T et al..
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
J Thromb Haemost.
2006;
4
295-306
-
12
Vaarala O, Palosuo T, Kleemola M, Aho K.
Anticardiolipin response in acute infections.
Clin Immunol Immunopathol.
1986;
41
8-15
-
13
Kurugol Z, Vardar F, Ozkinay F, Kavakli K, Ozkinay C.
Lupus anticoagulant and protein S deficiency in otherwise healthy children with acute varicella infection.
Acta Paediatr.
2000;
89
1186-1189
-
14
Manco-Johnson M J, Nuss R, Key N et al..
Lupus anticoagulant and protein S deficiency in children with post varicella purpura fulminans or thrombosis.
J Pediatr.
1996;
128
319-323
-
15
Levi M.
Measuring activated protein C in plasma to assess its role as a critical modulator of coagulation and inflammation.
J Thromb Haemost.
2003;
1
643-644
-
16
Rapizzi E, Ruffati A, Tonello M et al..
Correction of age of anticardiolipin antibodies cut-off points.
J Clin Lab Anal.
2000;
14
87-90
-
17
Caporali R, Ravelli A, De Gennaro F, Neirotti G, Montecucco C, Martini A.
Prevalence of anticardiolipin antibodies in juvenile arthritis.
Ann Rheum Dis.
1991;
50
599-601
-
18
Mavradis A K, Terzoglou C, Filopoulou S, Athanasiadou S, Tzioufas A G. Siamopoulou–Mavridou A .
Autoantibodies in Greek juvenile chronic arthritis patients.
Clin Exp Rheumatol.
1991;
9
647-652
-
19
Gattorno M, Buoncompagni A, Molinari A C et al..
Antiphospholipid antibodies in paediatric systemic lupus erythematosis, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome.
Br J Rheumatol.
1995;
34
873-881
-
20
Kontianes S, Miettinen A, Sepala I, Verkasalo M, Maenpaa J.
Antiphospholipid antibodies in children.
Acta Paediatr.
1996;
85
614-615
-
21
Serra C RB, Rodrigues S H, Silva N P, Szatajnbok F R, Andrade L EC.
Clinical significance of anticardiolipin antibodies in juvenile idiopathic arthritis.
Clin Exp Rheumatol.
1999;
17
375-380
-
22
Avcin T, Ambrozic A, Kuher H, Kveder T, Rozman B.
Anticardiolipin and anti-β2GPL antibodies in sera of 61 apparently healthy children at regular preventive visits.
Rheumatology.
2001;
40
565-573
-
23
Ambrozic A, Avein T, Ichikawa K et al..
Anti-β2GPI antibodies in children with atopic dematitis.
Int Immunol.
2002;
14
823-830
-
24
Male C, Lechner K, Eichinger S et al..
Clinical significance of lupus anticoagulants in children.
J Pediatr.
1999;
134
199-205
-
25
Gallistl S, Muntean W, Leschnik B, Meyers W.
Longer aPPT values in healthy children than in adults: no single cause.
Thromb Res.
1997;
88
355-359
-
26
Siemens H JG, Gutsche S, Bruckner S, Bucsky P, Katus H A.
Antiphospholipid antibodies in children without and in adults with and without thrombophilia.
Thromb Res.
2000;
98
241-247
-
27
Aguilar Franco C, Lucia Cuesta J.
Antiphospholipid antibodies in asymptomatic pediatric patients [in Spanish].
An Esp Pediatr.
2001;
54
444-449
-
28
Martinuc-Porobic J, Avein T, Bozic B et al..
Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine.
Clin Exp Immunol.
2005;
142
377-380
-
29
Ravelli A, Martini A.
Antiphospholipid antibody syndrome in pediatric patients.
Rheum Dis Clin North Am.
1997;
23
657-676
-
30 Tucker L B. Antiphospholipid antibodies and antiphospholipid syndromes in children. In: Khamashta MA Hughes Syndrome, Antiphospholipid Syndrome. London, England; Springer 2000: 155-166
-
31
Uysal Z, Dogu F, Kurekci A E et al..
Recurrent arterial thrombosis in a child: primary antiphospholipid antibody syndrome.
Pediatr Hematol Oncol.
2002;
19
59-66
-
32
Manco-Johnson M J, Nuss R.
Lupus anticoagulant in children with thrombosis.
Am J Hematol.
1995;
48
240-243
-
33
Falcini F, Taccetti G, Ermini M, Trapani S, Matucci Cerinic M.
Catastrophic antiphospholipid antibody syndrome in pediatric systemic lupus erythematosus.
J Rheumatol.
1997;
24
389-392
-
34
Angelini L, Zibordi F, Zorzi G et al..
Neurological disorders, other than stroke, associated with antiphospholipid antibodies in childhood.
Neuropediatrics.
1996;
27
149-153
-
35
Angelini L, Granata T, Zibordi F, Binelli S, Zorgi G, Besana C.
Partial seizures associated with antiphospholipid antibodies in childhood.
Neuropediatrics.
1998;
29
249-253
-
36
Tucker L B.
Antiphospholipid syndrome in childhood: the great unknown.
Lupus.
1994;
3
367-369
-
37
Ravelli A, Caporali R, Di Fuccia G, Zonta L, Montecucco C, Martini A.
Anticardiolipin antibodies in pediatric systemic lupus erythematosus.
Arch Pediatr Adolesc Med.
1994;
148
398-402
-
38
Seaman D E, Londino V, Kwoh C K, Medsger T A, Manzi S.
Antiphospholipid antibodies in pediatric systemic lupus erythematosis.
Pediatrics.
1995;
96
1040-1045
-
39
Shergy W J, Kredich D W, Pisetsky D S.
The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosis.
J Rheumatol.
1988;
15
1389-1394
-
40
Montes de Oca M A, Babron M C, Bletry O et al..
Thrombosis in systemic lupus erythematosus: a French collaborative study.
Arch Dis Child.
1991;
66
713-717
-
41
Molta C, Meyer O, Dosquet C et al..
Childhood-onset systemic lupus erythematosis: antiphospholipid antibodies in 37 patients and their first-degree relatives.
Pediatrics.
1993;
92
849-853
-
42
Massengill S F, Hedrick C, Ayoub E M, Sleasman J W, Kao K J.
Antiphospholipid antibodies in pediatric lupus nephritis.
Am J Kidney Dis.
1997;
29
355-361
-
43
Berube C, Mitchell L, Silverman E et al..
The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosis: a cross-sectional study.
Pediatr Res.
1998;
44
351-356
-
44
Gedalia A, Molina J F, Garcia C O, Doggett S, Espinoza L R, Gharavi A E.
Anticardiolipin antibodies in childhood rheumatic disorders.
Lupus.
1998;
7
551-553
-
45
Sugita K, Sato Y, Owada Y, Kurosawa H, Eguchi M.
Antiphospholipid antibody syndrome followed by systemic lupus erythematosus in a young male with clinical manifestations since infancy.
Pediatr Int.
2001;
43
563-564
-
46
Avčin T, Cimaz R, Meroni P L.
Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations.
Lupus.
2002;
11
4-10
-
47
Southwood T R, Roberts-Thomson P J, Ahern M J et al..
Autoantibodies in patients with juvenile chronic arthritis and their immediate family members.
Ann Rheum Dis.
1990;
49
968-972
-
48
Avein T, Benseler S M, Tyrrell P N, Cucnik S, Silverman E D.
Longitudinal follow-up study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus (in press).
Arthritis Rheum.
2008;
59
206-213
-
49
Levy D M, Massicotte M P, Harvey E, Herbert D, Silverman E D.
Thromboembolism in paediatric lupus patients.
Lupus.
2003;
12
741-746
-
50
Male C, Mitchell L, Julian J et al..
Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus.
Blood.
2001;
97
844-849
-
51
Male C, Foulon D, Hoogendoorn H et al..
Predictive value of persistent versus transient antiphospholipid antibody subtype for the risk of thrombotic events in pediatric patients with systemic lupus erythemasus.
Blood.
2005;
106
4152-4158
-
52
Miller D J, Maisch S A, Perez M D, Kearney D L, Feltes T F.
Fatal myocardial infarction in an 8-year-old girl with systemic lupus erythematosus, Raynaud's phenomenon, and secondary antiphospholipid syndrome.
J Rheumatol.
1995;
22
768-773
-
53
Angelini L, Ravelli A, Caporali R, Rumi V, Nardocci N, Martini A.
High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia.
Pediatrics.
1994;
94
500-503
-
54
Schöning M, Klein R, Krageloh-Mann I et al..
Antiphospholipid antibodies in cerebrovascular ischemia and stroke in childhood.
Neuropediatrics.
1994;
25
8-14
-
55
Takanashi J, Sugita K, Miyazato S, Sakao E, Miyamoto H, Niimi H.
Antiphospholipid antibody syndrome in childhood strokes.
Pediatr Neurol.
1995;
13
323-326
-
56
Baca V, Garcia-Ramirez R, Ramirez-Lacayo M, Marquez-Enriquez L, Martinez I, Lavalle C.
Cerebral infarction and antiphospholipid syndrome in children.
J Rheumatol.
1996;
23
1428-1431
-
57
Kenet G, Sadetzki S, Murad H et al..
Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children.
Stroke.
2000;
31
1283-1288
-
58
Pilarska E.
The significance of antiphospholipid antibodies in ischemic stroke in children in light of the most current studies [in Polish].
Przegl Lek.
2001;
58
22-24
-
59
deVeber G, Andrews M, Adams C for the Canadian Pediatric Ischemic Stroke Study Group et al.
Cerebral sinovenous thrombosis in children.
N Engl J Med.
2001;
345
417-423
-
60
Vlachoyiannopoulos P G, Dimou G, Siamopoulou-Mavridou A.
Chorea as a manifestation of the antiphospholipid syndrome in childhood.
Clin Exp Rheumatol.
1991;
9
303-305
-
61
Besbas N, Damargue I, Ozen S, Aysun S, Saatci U.
Association of antiphospholipid antibodies with systemic lupus erythematosus in a child presenting with chorea: a case report.
Eur J Pediatr.
1994;
153
891-893
-
62
Okun M S, Jummani R R, Carney P R.
Antiphospholipid–associated recurrent chorea and ballism in a child with cerebral palsy.
Pediatr Neurol.
2000;
23
62-63
-
63
Al-Matar M, Jaimes J, Malleson P.
Chorea as the presenting clinical feature of primary antiphospholipid syndrome in childhood.
Neuropediatrics.
2000;
31
107-108
-
64
Hasegawa M, Yamashita J, Yamashita T, Ikeda K, Fujishima Y, Yamazaki M.
Spinal cord infarction associated with primary antiphospholipid syndrome in a young child. Case report.
J Neurosurg.
1993;
79
446-450
-
65
Besbas N, Anlar B, Apak A, Kansu T.
Optic neuropathy in primary antiphospholipid syndrome in childhood.
J Child Neurol.
2001;
16
690-693
-
66
Rumi V, Angelini L, Scioli V, D'Angelo A, Besana C.
Primary antiphospholipid syndrome and neurologic events.
Pediatr Neurol.
1993;
9
473-475
-
67
Agarwal K S, Puliyel J M, Khanduri U.
Sudden onset profound deafness in association with antiphospholipid antibodies in a child with SLE.
Indian Pediatr.
2000;
37
1274-1276
-
68
Booth F, Yanofsky R, Ross I B, Lawrence P, Oen K.
Primary antiphospholipid syndrome with moyamoya-like vascular changes.
Pediatr Neurosurg.
1999;
31
45-48
-
69
Harel L, Sandborg C, Lee Tvon Scheven E.
Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies.
J Rheumatol.
2006;
33
1873-1877
-
70
Avcin T, Benseler S M, Tyrell P N, Cucnik S, Silverman E D.
A follow-up study of antiphospholipid antibodies and associated neurophychiatric manifestations in 137 children with systemic lupus erythematosus.
Arthritis Rheum.
2008;
59
206-213
-
71
Eriksson K, Peltola J, Keranen T, Haapala A M, Koivikko M.
High prevalence of antiphospholipid antibodies in children with epilepsy: a controlled study of 50 cases.
Epilepsy Res.
2001;
46
129-137
-
72
Purandare A, Godil M A, Prakash D, Parker R, Zerah M, Wilson T A.
Spontaneous adrenal hemorrhage associated with transient antiphospholipid antibody in a child.
Clin Pediatr (Phila).
2001;
40
347-350
-
73
Becton D L, Stine K C.
Transient lupus anticoagulants associated with hemorrhage rather than thrombosis: the hemorrhagic lupus anticoagulant syndrome.
J Pediatr.
1997;
130
998-1000
-
74
Yacobovich J R, Uziel Y, Friedman Z, Radnay J, Wolach B.
Diffuse muscular haemorrhage as presenting sign of juvenile systemic lupus erythematosus and lupus anticoagulant hypoprothrombinaemia syndrome.
Rheumatology.
2001;
40
585-587
-
75
Boffa M C, Lachassinne E.
Infant perinatal thrombosis and antiphospholipid antibodies: a review.
Lupus.
2007;
16
634-641
-
76
Ohtomo Y, Nagaoka R, Watanabe H, Kaneko K, Ohyama S, Yamashiro Y.
Non-lupus nephropathy associated with antiphospholipid antibodies.
Pediatr Nephrol.
2000;
15
136-138
-
77
Minisola G, Porzio V, Bancheri C, Ceralli F, Carnabuci A, Onetti Muda A.
Atypical renal onset and involvement in primary antiphospholipid syndrome in a child.
Clin Exp Rheumatol.
1998;
16
102-104
-
78
Monastiri K, Selmi H, Tabarki B, Yacoub M, Mahjoub T, Essoussi A S.
Primary antiphospholipid syndrome presenting as complicated Henoch-Schonlein purpura.
Arch Dis Child.
2002;
86
132-133
-
79
Rongioletti F, Ghio L, Ginevri F et al..
Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children.
Br J Dermatol.
1999;
140
948-951
-
80
Monagle P, Michelson A D, Bovill W, Andrews M.
Antithrombioic therapy in children.
Chest.
2001;
119
344S-370S
-
81
Massicotte P, Adams M, Marzinotto V, Brooker L A, Andrew M.
Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study.
J Pediatr.
1996;
128
313-318
-
82
Burak C R, Bowen M D, Barron T F.
The use of enoxaparin in children with acute, nonhemorrhagic ischemic stroke.
Pediatr Neurol.
2003;
29
295-298
-
83
Dix D, Andrew M, Marzinotto V et al..
The use of low-molecular-weight heparin in pediatric patients: a prospective cohort study.
J Pediatr.
2000;
136
439-445
-
84
Punzalan R C, Hillery C A, Montgomery R R, Scott J P, Gill J C.
Low-molecular-weight heparin in thrombotic disease in children and adolescents.
J Pediatr Hematol Oncol.
2000;
22
137-142
-
85
Albisetti M, Andrew M.
Low molecular weight heparin in children.
Eur J Pediatr.
2002;
161
71-77
-
86
Erkan D, Lockshin M D.
New treatments for antiphospholipid syndrome.
Rheum Dis Clin North Am.
2006;
32
129-148
-
87
Buck M L.
Anticoagulation with warfarin in infants and children.
Ann Pharmacother.
1996;
30
1316-1322
-
88
Doyle J J, Koren G, Cheng M Y, Blanchette V S.
Anticoagulation with sodium warfarin in children: effect of a loading regimen.
J Pediatr.
1988;
113
1095-1097
-
89
Crowther M A, Ginsberg J S, Julian J et al..
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.
N Engl J Med.
2003;
349
1133-1138
-
90
Finazzi G, Marchioli R, Brancaccio V et al..
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).
J Thromb Haemost.
2005;
3
848-853
-
91
Khamashta M A, Hunt B J.
Moderate-dose oral anticoagulant therapy in patients with the antiphospholipid syndrome?.
J Thromb Haemost.
2005;
3
844-845
B. J HuntM.D. F.R.C.P. F.R.C.Path.
Department of Haematology, St Thomas' Hospital
London SE1 7EH, United Kingdom
Email: Beverley.hunt@gstt.nhs.uk
